Apellis Pharmaceuticals, Inc. · NASDAQ:APLS
Boucher Kelley disposed of 142,877 Apellis Pharmaceuticals, Inc. shares (Form 4)
Traded May 14, 2026 · Filed May 14, 2026
On May 14, 2026, Boucher Kelley (Chief People Officer) disposed of 142,877 Apellis Pharmaceuticals, Inc. shares, leaving 0 shares. Filed May 14, 2026 (Form 4).
- Disposed of
- 142,877 shares
- Holding after
- 0 shares
- Trading plan
- No
- Role
- Chief People Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 14, 2026 | Common Stock | Other | 127,804 | 0 | Direct | |
| May 14, 2026 | Common Stock | Award | 15,073 | 15,073 | Direct | |
| May 14, 2026 | Common Stock | Disposition | 15,073 | 0 | Direct | |
| May 14, 2026 | Common Stock | Award | 30,146 | 30,146 | Direct | |
| May 14, 2026 | Common Stock | Disposition | 22,087 | 0 | Direct | |
| May 14, 2026 | Common Stock | Disposition | 45,095 | 0 | Direct | |
| May 14, 2026 | Common Stock | Disposition | 30,476 | 0 | Direct | |
| May 14, 2026 | Common Stock | Disposition | 30,146 | 0 | Direct |
Source
Related
- Apellis Pharmaceuticals, Inc.
- Boucher Kelley
- Apellis Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · Morgan Stanley · Jun 5, 2026
- Schedule 13G/A · Deep Track Capital, LP · May 15, 2026
- Schedule 13G/A · Rtw Investments, LP · May 15, 2026
- Form 4 · Dunlop A. Sinclair · May 14, 2026
- Form 4 · Chopas James George · May 14, 2026